ALK nominates former Sanofi executive for board membership

Allergy company ALK has nominated Alan Main, former Sanofi Head of Consumer Healthcare, to be its new board member. He will replace Vincent Warnery, who is leaving the board of ALK after being appointed CEO of cosmetics company Beiersdorf.

Nominee for the board of ALK Alan Main | Photo: ALK / PR

Denmark-based allergy and immunotherapy company ALK plans to maintain the company's focus on digital offers such as consumer-oriented services,for which reason it nominates the former head of consumer healthcare at Sanofi, Alan Main, for a place on the board of the firm at the future general meeting, which is scheduled for March next year, according to an ALK press release.

If shareholders formally vote Main into the board, he will be taking over after Vincent Warnery, who was elected for the ALK board in March 2019 with the hopes that he could help boost the consumer healthcare business.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

CHMP to remove 100 generic medicines from market

Due to fraudulent clinical trials from a contract research organization, the EMA’s expert committee, the CHMP, is now suspending marketing approval authorizations for around 100 generic drugs on the market.

Further reading

Related articles

Latest news

See all jobs